Skip to content

Clinical trials

Completed Phase 2 Post-Acute COVID-19 Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Phase 2 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20215
20228
202314
20248
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kanecia Obie Zimmerman5
Duke University3
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia2
AIM ImmunoTech Inc.1
AgelessRx1
Axcella Health, Inc1
Bateman Horne Center1
Berlin Cures GmbH1
BioVie Inc.1
Bod Australia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome40
COVID-1913
Fatigue4
Mental Fatigue4
Infections3
Parasomnias3
Coronavirus Infections2
Disorders of Excessive Somnolence2
Postural Orthostatic Tachycardia Syndrome2
Anosmia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.